Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 33 | 2023 | 1373 | 9.010 |
Why?
|
| Primary Health Care | 18 | 2023 | 339 | 4.860 |
Why?
|
| Diabetes Mellitus | 19 | 2023 | 806 | 4.270 |
Why?
|
| Psychiatry | 4 | 2023 | 78 | 3.310 |
Why?
|
| Blood Glucose | 13 | 2023 | 873 | 2.890 |
Why?
|
| Hypoglycemic Agents | 11 | 2023 | 378 | 2.420 |
Why?
|
| Diabetes Complications | 11 | 2023 | 207 | 2.400 |
Why?
|
| Physicians | 7 | 2022 | 673 | 2.320 |
Why?
|
| Depression | 8 | 2023 | 473 | 2.070 |
Why?
|
| Aging | 10 | 2023 | 691 | 1.830 |
Why?
|
| Medicaid | 7 | 2022 | 217 | 1.730 |
Why?
|
| Mass Screening | 6 | 2021 | 618 | 1.590 |
Why?
|
| Humans | 93 | 2023 | 86643 | 1.560 |
Why?
|
| Mental Health Services | 2 | 2021 | 48 | 1.410 |
Why?
|
| Hypothyroidism | 4 | 2023 | 232 | 1.340 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 3 | 2023 | 35 | 1.260 |
Why?
|
| Healthcare Disparities | 4 | 2022 | 371 | 1.240 |
Why?
|
| Nutrition Surveys | 7 | 2023 | 114 | 1.240 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2021 | 57 | 1.230 |
Why?
|
| Cardiovascular Diseases | 5 | 2023 | 827 | 1.210 |
Why?
|
| Documentation | 3 | 2022 | 98 | 1.200 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2019 | 66 | 1.190 |
Why?
|
| Depressive Disorder, Major | 2 | 2019 | 158 | 1.180 |
Why?
|
| United States | 22 | 2023 | 6672 | 1.170 |
Why?
|
| Physicians, Primary Care | 2 | 2020 | 104 | 1.130 |
Why?
|
| Cross-Sectional Studies | 15 | 2023 | 1621 | 0.980 |
Why?
|
| Patient Portals | 1 | 2023 | 15 | 0.910 |
Why?
|
| Chronic Disease | 4 | 2022 | 971 | 0.900 |
Why?
|
| Insurance | 1 | 2022 | 11 | 0.870 |
Why?
|
| Hormone Replacement Therapy | 2 | 2022 | 77 | 0.870 |
Why?
|
| Population Health | 1 | 2022 | 33 | 0.860 |
Why?
|
| Adult | 25 | 2023 | 25648 | 0.850 |
Why?
|
| Hyperthyroidism | 1 | 2022 | 75 | 0.840 |
Why?
|
| Outpatients | 1 | 2022 | 94 | 0.830 |
Why?
|
| Systems Integration | 2 | 2021 | 35 | 0.830 |
Why?
|
| Health Services Accessibility | 4 | 2021 | 394 | 0.830 |
Why?
|
| Schools, Medical | 1 | 2023 | 123 | 0.820 |
Why?
|
| Hospitalization | 3 | 2021 | 849 | 0.820 |
Why?
|
| Quality of Life | 7 | 2021 | 1585 | 0.800 |
Why?
|
| Thyroid Hormones | 2 | 2023 | 321 | 0.770 |
Why?
|
| Female | 39 | 2023 | 44532 | 0.770 |
Why?
|
| Metformin | 1 | 2022 | 128 | 0.770 |
Why?
|
| Aged | 29 | 2023 | 18415 | 0.760 |
Why?
|
| Quality-Adjusted Life Years | 6 | 2022 | 138 | 0.760 |
Why?
|
| Financing, Organized | 1 | 2020 | 12 | 0.750 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2020 | 22 | 0.740 |
Why?
|
| Breast Density | 1 | 2020 | 31 | 0.730 |
Why?
|
| Male | 36 | 2023 | 40965 | 0.730 |
Why?
|
| Glucose Tolerance Test | 1 | 2020 | 228 | 0.720 |
Why?
|
| Middle Aged | 28 | 2021 | 25028 | 0.720 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2023 | 350 | 0.710 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 288 | 0.710 |
Why?
|
| State Health Plans | 1 | 2019 | 14 | 0.700 |
Why?
|
| Program Evaluation | 1 | 2020 | 297 | 0.690 |
Why?
|
| Early Medical Intervention | 1 | 2018 | 18 | 0.660 |
Why?
|
| Veterans | 1 | 2019 | 72 | 0.660 |
Why?
|
| Quality of Health Care | 3 | 2022 | 380 | 0.660 |
Why?
|
| Cost-Benefit Analysis | 7 | 2022 | 454 | 0.640 |
Why?
|
| Clinical Decision-Making | 2 | 2019 | 257 | 0.640 |
Why?
|
| Community Health Centers | 2 | 2022 | 113 | 0.630 |
Why?
|
| Delivery of Health Care | 5 | 2023 | 426 | 0.590 |
Why?
|
| Public Health | 2 | 2021 | 129 | 0.580 |
Why?
|
| Quality Improvement | 2 | 2017 | 428 | 0.580 |
Why?
|
| Health Policy | 2 | 2016 | 180 | 0.570 |
Why?
|
| Cost Sharing | 3 | 2023 | 14 | 0.570 |
Why?
|
| Communication | 1 | 2020 | 441 | 0.560 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2016 | 3 | 0.560 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 394 | 0.560 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 484 | 0.550 |
Why?
|
| Hypertension | 3 | 2016 | 1141 | 0.550 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2019 | 332 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 567 | 0.550 |
Why?
|
| Patient Preference | 1 | 2016 | 105 | 0.540 |
Why?
|
| Coronavirus Infections | 1 | 2021 | 301 | 0.540 |
Why?
|
| Attitude to Health | 1 | 2016 | 220 | 0.520 |
Why?
|
| Opioid-Related Disorders | 3 | 2022 | 161 | 0.520 |
Why?
|
| Glucose | 3 | 2022 | 638 | 0.520 |
Why?
|
| Medication Adherence | 1 | 2016 | 129 | 0.520 |
Why?
|
| Insurance Coverage | 2 | 2019 | 117 | 0.510 |
Why?
|
| Risk Assessment | 4 | 2021 | 2261 | 0.490 |
Why?
|
| Leadership | 2 | 2017 | 134 | 0.490 |
Why?
|
| Preventive Health Services | 1 | 2014 | 37 | 0.480 |
Why?
|
| Obesity | 2 | 2011 | 963 | 0.480 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 1036 | 0.480 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 3640 | 0.470 |
Why?
|
| Surveys and Questionnaires | 8 | 2023 | 2501 | 0.470 |
Why?
|
| Health Care Reform | 2 | 2015 | 90 | 0.460 |
Why?
|
| Coronary Disease | 1 | 2014 | 261 | 0.440 |
Why?
|
| Medicare | 3 | 2023 | 410 | 0.440 |
Why?
|
| Bariatric Surgery | 2 | 2017 | 194 | 0.440 |
Why?
|
| Comorbidity | 5 | 2018 | 943 | 0.410 |
Why?
|
| Informed Consent | 2 | 2023 | 266 | 0.390 |
Why?
|
| Sodium | 2 | 2022 | 341 | 0.390 |
Why?
|
| Ambulatory Care Facilities | 2 | 2022 | 102 | 0.380 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 160 | 0.370 |
Why?
|
| Thyroxine | 4 | 2023 | 344 | 0.350 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 220 | 0.350 |
Why?
|
| Markov Chains | 2 | 2020 | 125 | 0.340 |
Why?
|
| Monte Carlo Method | 2 | 2020 | 185 | 0.330 |
Why?
|
| Models, Economic | 2 | 2020 | 60 | 0.330 |
Why?
|
| Life Expectancy | 3 | 2023 | 86 | 0.310 |
Why?
|
| Thyrotropin | 3 | 2023 | 280 | 0.310 |
Why?
|
| Prospective Studies | 6 | 2023 | 4213 | 0.300 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 2705 | 0.280 |
Why?
|
| Appointments and Schedules | 2 | 2023 | 53 | 0.280 |
Why?
|
| Attitude of Health Personnel | 3 | 2022 | 636 | 0.270 |
Why?
|
| Chronic Pain | 2 | 2022 | 145 | 0.270 |
Why?
|
| Young Adult | 6 | 2019 | 5976 | 0.260 |
Why?
|
| Job Satisfaction | 2 | 2018 | 73 | 0.260 |
Why?
|
| Costs and Cost Analysis | 3 | 2020 | 153 | 0.260 |
Why?
|
| Triiodothyronine | 2 | 2023 | 339 | 0.250 |
Why?
|
| Health Care Surveys | 2 | 2019 | 278 | 0.250 |
Why?
|
| Internship and Residency | 2 | 2011 | 1004 | 0.250 |
Why?
|
| Disease Progression | 3 | 2018 | 1531 | 0.240 |
Why?
|
| Efficiency | 2 | 2021 | 40 | 0.240 |
Why?
|
| Physician-Patient Relations | 3 | 2016 | 610 | 0.230 |
Why?
|
| Parental Leave | 1 | 2023 | 9 | 0.230 |
Why?
|
| Logistic Models | 2 | 2019 | 1186 | 0.230 |
Why?
|
| Insurance, Health | 2 | 2015 | 160 | 0.220 |
Why?
|
| Prevalence | 2 | 2019 | 1239 | 0.220 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2022 | 9 | 0.220 |
Why?
|
| Faculty | 1 | 2023 | 30 | 0.220 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 413 | 0.220 |
Why?
|
| Academic Medical Centers | 3 | 2023 | 379 | 0.220 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 48 | 0.220 |
Why?
|
| Organizational Policy | 1 | 2023 | 55 | 0.220 |
Why?
|
| Antipsychotic Agents | 1 | 2023 | 123 | 0.210 |
Why?
|
| Buprenorphine | 1 | 2022 | 33 | 0.210 |
Why?
|
| Fee-for-Service Plans | 1 | 2022 | 30 | 0.210 |
Why?
|
| Waiting Lists | 1 | 2023 | 175 | 0.210 |
Why?
|
| Aged, 80 and over | 7 | 2023 | 6509 | 0.210 |
Why?
|
| Dementia | 1 | 2023 | 187 | 0.200 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2022 | 103 | 0.200 |
Why?
|
| Health Care Costs | 2 | 2020 | 238 | 0.190 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 98 | 0.190 |
Why?
|
| Pilot Projects | 2 | 2020 | 839 | 0.180 |
Why?
|
| Risk Factors | 4 | 2023 | 5417 | 0.180 |
Why?
|
| Opiate Substitution Treatment | 1 | 2020 | 30 | 0.180 |
Why?
|
| Computers | 1 | 2020 | 112 | 0.180 |
Why?
|
| Time Factors | 4 | 2021 | 5210 | 0.180 |
Why?
|
| Pandemics | 2 | 2023 | 740 | 0.180 |
Why?
|
| Emotions | 1 | 2023 | 341 | 0.180 |
Why?
|
| Fasting | 1 | 2020 | 161 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 865 | 0.180 |
Why?
|
| Hospitals | 1 | 2022 | 294 | 0.180 |
Why?
|
| Interviews as Topic | 2 | 2019 | 319 | 0.170 |
Why?
|
| California | 3 | 2015 | 138 | 0.170 |
Why?
|
| Length of Stay | 1 | 2022 | 702 | 0.170 |
Why?
|
| Withholding Treatment | 1 | 2019 | 112 | 0.170 |
Why?
|
| Demography | 2 | 2023 | 177 | 0.170 |
Why?
|
| Internal Medicine | 4 | 2021 | 347 | 0.170 |
Why?
|
| Electronic Health Records | 2 | 2021 | 319 | 0.160 |
Why?
|
| Insulin | 2 | 2023 | 1160 | 0.160 |
Why?
|
| Allied Health Personnel | 1 | 2018 | 19 | 0.160 |
Why?
|
| Retrospective Studies | 5 | 2023 | 8489 | 0.160 |
Why?
|
| Work Engagement | 1 | 2017 | 6 | 0.160 |
Why?
|
| Health Status Disparities | 2 | 2023 | 170 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2023 | 2767 | 0.160 |
Why?
|
| Sepsis | 1 | 2021 | 306 | 0.160 |
Why?
|
| Blood Pressure | 2 | 2015 | 1143 | 0.160 |
Why?
|
| Poverty | 1 | 2019 | 173 | 0.160 |
Why?
|
| Inservice Training | 1 | 2017 | 38 | 0.160 |
Why?
|
| Urban Health Services | 1 | 2017 | 45 | 0.150 |
Why?
|
| Patient Participation | 1 | 2019 | 216 | 0.150 |
Why?
|
| Cost Savings | 1 | 2017 | 66 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2019 | 487 | 0.150 |
Why?
|
| Diet Therapy | 1 | 2016 | 20 | 0.150 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1019 | 0.150 |
Why?
|
| Financing, Personal | 1 | 2016 | 21 | 0.140 |
Why?
|
| Perception | 1 | 2017 | 168 | 0.140 |
Why?
|
| Sexual and Gender Minorities | 1 | 2019 | 192 | 0.140 |
Why?
|
| Patient Care Planning | 1 | 2016 | 81 | 0.140 |
Why?
|
| Linear Models | 2 | 2018 | 421 | 0.140 |
Why?
|
| Safety-net Providers | 1 | 2016 | 37 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 746 | 0.140 |
Why?
|
| Overweight | 1 | 2017 | 118 | 0.140 |
Why?
|
| Drug Monitoring | 1 | 2016 | 118 | 0.140 |
Why?
|
| Medical Overuse | 1 | 2016 | 36 | 0.140 |
Why?
|
| Life Style | 1 | 2016 | 189 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1801 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2016 | 256 | 0.130 |
Why?
|
| Phenotype | 1 | 2021 | 2378 | 0.130 |
Why?
|
| Data Accuracy | 1 | 2015 | 31 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 455 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2018 | 1538 | 0.130 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2015 | 57 | 0.120 |
Why?
|
| Federal Government | 1 | 2014 | 29 | 0.120 |
Why?
|
| Medically Uninsured | 1 | 2014 | 58 | 0.120 |
Why?
|
| Health Surveys | 2 | 2013 | 239 | 0.120 |
Why?
|
| Statistics as Topic | 1 | 2015 | 238 | 0.120 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 222 | 0.120 |
Why?
|
| Primary Prevention | 2 | 2013 | 85 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2018 | 1078 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2015 | 319 | 0.110 |
Why?
|
| Registries | 2 | 2013 | 702 | 0.110 |
Why?
|
| Musculoskeletal Pain | 1 | 2012 | 10 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 364 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2014 | 678 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2022 | 7993 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2017 | 770 | 0.110 |
Why?
|
| Adolescent | 3 | 2019 | 8981 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 384 | 0.100 |
Why?
|
| United Kingdom | 1 | 2012 | 164 | 0.100 |
Why?
|
| Blood Pressure Determination | 1 | 2012 | 90 | 0.100 |
Why?
|
| Medical Audit | 1 | 2011 | 41 | 0.100 |
Why?
|
| Burnout, Professional | 1 | 2013 | 94 | 0.100 |
Why?
|
| Prognosis | 2 | 2016 | 3679 | 0.100 |
Why?
|
| Health Status | 2 | 2023 | 360 | 0.100 |
Why?
|
| Hypoglycemia | 1 | 2011 | 107 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2010 | 162 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2011 | 203 | 0.090 |
Why?
|
| Disease Management | 1 | 2011 | 327 | 0.090 |
Why?
|
| Counseling | 1 | 2009 | 145 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1991 | 0.070 |
Why?
|
| Stroke | 1 | 2015 | 965 | 0.070 |
Why?
|
| Chicago | 1 | 2011 | 1379 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 351 | 0.070 |
Why?
|
| Insulin Glargine | 1 | 2023 | 9 | 0.060 |
Why?
|
| Algorithms | 1 | 2011 | 1830 | 0.060 |
Why?
|
| Sulfonylurea Compounds | 1 | 2023 | 64 | 0.060 |
Why?
|
| Thyroid Function Tests | 1 | 2023 | 119 | 0.060 |
Why?
|
| Buprenorphine, Naloxone Drug Combination | 1 | 2022 | 5 | 0.060 |
Why?
|
| Dronabinol | 1 | 2023 | 53 | 0.060 |
Why?
|
| Methadone | 1 | 2022 | 36 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 148 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2022 | 65 | 0.050 |
Why?
|
| Systems Analysis | 1 | 2021 | 17 | 0.050 |
Why?
|
| Anxiety | 1 | 2023 | 287 | 0.050 |
Why?
|
| Naltrexone | 1 | 2022 | 135 | 0.050 |
Why?
|
| Jurisprudence | 1 | 2021 | 25 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 361 | 0.050 |
Why?
|
| Community Networks | 1 | 2021 | 29 | 0.050 |
Why?
|
| Illinois | 1 | 2021 | 462 | 0.050 |
Why?
|
| Social Stigma | 1 | 2019 | 52 | 0.040 |
Why?
|
| Survival Rate | 2 | 2014 | 1863 | 0.040 |
Why?
|
| Economics, Medical | 1 | 2018 | 6 | 0.040 |
Why?
|
| Mental Health | 1 | 2019 | 162 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 287 | 0.040 |
Why?
|
| Checklist | 1 | 2018 | 57 | 0.040 |
Why?
|
| Australia | 1 | 2017 | 99 | 0.040 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2016 | 8 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2022 | 582 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2017 | 150 | 0.040 |
Why?
|
| Animals | 1 | 2015 | 26582 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 229 | 0.030 |
Why?
|
| Philippines | 1 | 2015 | 23 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2015 | 51 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 48 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 594 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 567 | 0.030 |
Why?
|
| Clinical Audit | 1 | 2013 | 9 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1686 | 0.030 |
Why?
|
| New York City | 1 | 2013 | 59 | 0.030 |
Why?
|
| Midwestern United States | 1 | 2013 | 76 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 912 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2012 | 27 | 0.030 |
Why?
|
| Family Practice | 1 | 2013 | 84 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2012 | 173 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 999 | 0.030 |
Why?
|
| Age Distribution | 1 | 2012 | 204 | 0.030 |
Why?
|
| Medical Errors | 1 | 2013 | 115 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 2216 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2013 | 223 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1577 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Data Collection | 1 | 2009 | 372 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 324 | 0.020 |
Why?
|